WO2005102379A3 - Nucleic acid based assays for identification of fc receptor polymorphisms - Google Patents

Nucleic acid based assays for identification of fc receptor polymorphisms Download PDF

Info

Publication number
WO2005102379A3
WO2005102379A3 PCT/US2004/043726 US2004043726W WO2005102379A3 WO 2005102379 A3 WO2005102379 A3 WO 2005102379A3 US 2004043726 W US2004043726 W US 2004043726W WO 2005102379 A3 WO2005102379 A3 WO 2005102379A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
identification
based assays
acid based
receptor polymorphisms
Prior art date
Application number
PCT/US2004/043726
Other languages
French (fr)
Other versions
WO2005102379A2 (en
Inventor
Pablo G Garcia
Susan E Wilson
Gene Guozhong Zhang
Original Assignee
Chiron Corp
Pablo G Garcia
Susan E Wilson
Gene Guozhong Zhang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp, Pablo G Garcia, Susan E Wilson, Gene Guozhong Zhang filed Critical Chiron Corp
Priority to JP2007507303A priority Critical patent/JP2007532110A/en
Priority to AU2004318681A priority patent/AU2004318681A1/en
Priority to EP04815738A priority patent/EP1732939A4/en
Priority to CA002562016A priority patent/CA2562016A1/en
Priority to BRPI0418722-9A priority patent/BRPI0418722A/en
Publication of WO2005102379A2 publication Critical patent/WO2005102379A2/en
Publication of WO2005102379A3 publication Critical patent/WO2005102379A3/en
Priority to IL178333A priority patent/IL178333A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Oligonucleotides specific for FcϜRIII polymorphisms are disclosed. Also disclosed are nucleic acid-based genotyping assays using the oligonucleotides described herein as amplification and/or sequencing primers.
PCT/US2004/043726 2004-04-07 2004-12-22 Nucleic acid based assays for identification of fc receptor polymorphisms WO2005102379A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2007507303A JP2007532110A (en) 2004-04-07 2004-12-22 Nucleic acid based assays for identification of Fc receptor polymorphisms
AU2004318681A AU2004318681A1 (en) 2004-04-07 2004-12-22 Nucleic acid based assays for identification of FC receptor polymorphisms
EP04815738A EP1732939A4 (en) 2004-04-07 2004-12-22 Nucleic acid based assays for identification of fc receptor polymorphisms
CA002562016A CA2562016A1 (en) 2004-04-07 2004-12-22 Nucleic acid based assays for identification of fc receptor polymorphisms
BRPI0418722-9A BRPI0418722A (en) 2004-04-07 2004-12-22 nucleic acid-based assays for identification of fc receptor polymorphisms
IL178333A IL178333A0 (en) 2004-04-07 2006-09-27 Nucleic acid based assays for identification of fc receptor polymorphisms

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56064904P 2004-04-07 2004-04-07
US60/560,649 2004-04-07

Publications (2)

Publication Number Publication Date
WO2005102379A2 WO2005102379A2 (en) 2005-11-03
WO2005102379A3 true WO2005102379A3 (en) 2006-02-16

Family

ID=35197498

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/043726 WO2005102379A2 (en) 2004-04-07 2004-12-22 Nucleic acid based assays for identification of fc receptor polymorphisms

Country Status (10)

Country Link
EP (1) EP1732939A4 (en)
JP (1) JP2007532110A (en)
KR (1) KR20070004082A (en)
CN (1) CN1976942A (en)
AU (1) AU2004318681A1 (en)
BR (1) BRPI0418722A (en)
CA (1) CA2562016A1 (en)
IL (1) IL178333A0 (en)
RU (1) RU2006138865A (en)
WO (1) WO2005102379A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090181016A1 (en) * 2005-11-30 2009-07-16 University Of Southern California FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME
EP2109686A2 (en) 2007-01-18 2009-10-21 University Of Southern California Genetic markers for predicting responsiveness to combination therapy
WO2009026502A1 (en) * 2007-08-22 2009-02-26 Wyeth Nested pcr-based method for specific genotyping of the fc-gamma receptor iiia gene
JP2016534749A (en) * 2013-10-15 2016-11-10 コネクシオ ゲノミクス ピーティーワイ リミテッド Major histocompatibility complex single nucleotide polymorphism
WO2021146521A1 (en) * 2020-01-16 2021-07-22 Acepodia Biotechnologies Ltd. A novel cd16+ natural killer cell and a method of culturing cd16+ natural killer cell
CN114277149B (en) * 2021-12-30 2023-09-22 苏州方科生物科技有限公司 Kit for detecting polymorphism of CD16A gene and application and use method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639611A (en) * 1988-12-12 1997-06-17 City Of Hope Allele specific polymerase chain reaction

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002346999B2 (en) * 2001-10-19 2007-11-08 Centre Hospitalier Regional Et Universitaire De Tours Methods and compositions to evaluate antibody treatment response

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639611A (en) * 1988-12-12 1997-06-17 City Of Hope Allele specific polymerase chain reaction

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
AHERN H ET AL: "Biochemical, Reagent Kits Offer Scientists Good Return on Investment.", THE SCIENTIST., vol. 9, no. 15, July 1995 (1995-07-01), pages 1 - 5, XP002921157 *
LEPPERS-VAN DE STRAAT FGJ ET AL: "A Novel PCR-Based Method for Direct Fc Gamma Receptor IIIa (CD16) Allotyping.", JOURNAL OF IMMUNOLOGICAL METHODS., vol. 242, no. 1-2, 28 August 2000 (2000-08-28), pages 127 - 132, XP004210716 *

Also Published As

Publication number Publication date
JP2007532110A (en) 2007-11-15
EP1732939A2 (en) 2006-12-20
EP1732939A4 (en) 2008-09-17
CN1976942A (en) 2007-06-06
RU2006138865A (en) 2008-05-20
KR20070004082A (en) 2007-01-05
IL178333A0 (en) 2007-02-11
WO2005102379A2 (en) 2005-11-03
CA2562016A1 (en) 2005-11-03
BRPI0418722A (en) 2007-09-11
AU2004318681A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
WO2008046602A3 (en) 2'-terminator related pyrophosphorolysis activated polymerization
WO2007075967A3 (en) Sequencing and genotyping using reversibly 2'-modified nucleotides
WO2007123744A3 (en) Systems and devices for sequence by synthesis analysis
WO2006007207A3 (en) Methods and devices for nucleic acid sequence determination
WO2003097794A3 (en) Universal-tagged oligonucleotide primers and methods of use
WO2006074351A3 (en) Reversible nucleotide terminators and uses thereof
WO2001094630A3 (en) Compositions and methods for array-based nucleic acid hybridization
WO2005044836A3 (en) Macromolecular nucleotide compounds and methods for using the same
HK1184195A1 (en) Multi-stage nucleic acid amplification reactions
WO2009073345A3 (en) Assay for detecting genetic abnormalities in genomic nucleic acids
AU2003303396A1 (en) Comparative genomic hybridization assays using immobilized oligonucleotide features and compositions for practicing the same
WO2009092035A3 (en) Methods and compositions for the analysis of biological molecules
EP1765856A4 (en) Rna-dependent dna polymerase from geobacillus stearothermophilus
WO2008077017A3 (en) Stabilized compositions of thermostable dna polymerase and anionic or zwitterionic detergent
WO2009059317A3 (en) Predicting amd with snps within or near c2, factor b, plekha1, htra1, prelp, or loc387715
WO2005089110A3 (en) Polynucleotide synthesis
WO2007070640A3 (en) Use of roma for characterizing genomic rearrangements
WO2007004057A3 (en) Chromosome conformation capture-on-chip (4c) assay
WO2005070104A3 (en) REAL-TIME POLYMERASE CHAIN REACTION-BASED GENOTYPING ASSAY FOR β2-ADRENERGIC RECEPTOR SINGLE NUCLEODITE POLYMORPHISM
EP1941058A4 (en) Nucleic acid amplification using non-random primers
WO2004068112A3 (en) Hairpin primer amplification
WO2008043543A3 (en) Nucleic acid beacons for fluorescent in-situ hybridisation and chip technology
WO2006039673A3 (en) Primers, methods and kits for amplifying or detecting human leukocyte antigen alleles
EP1979490A4 (en) MITIGATION OF Cot-1 DNA DISTORTION IN NUCLEIC ACID HYBRIDIZATION
GB0621361D0 (en) Use of DNA polymerases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004318681

Country of ref document: AU

Ref document number: 178333

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2562016

Country of ref document: CA

Ref document number: 2007507303

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: PA/a/2006/011476

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 200480042843.2

Country of ref document: CN

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2004815738

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: DE

ENP Entry into the national phase

Ref document number: 2004318681

Country of ref document: AU

Date of ref document: 20041222

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004318681

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 3155/KOLNP/2006

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 1020067022960

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2006138865

Country of ref document: RU

WWP Wipo information: published in national office

Ref document number: 2004815738

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020067022960

Country of ref document: KR

ENP Entry into the national phase

Ref document number: PI0418722

Country of ref document: BR